Gritstone Oncology, Inc. Skyrocketed

Tue, Nov 30, 2021 at 05:30 PM
Gritstone Oncology, Inc. Skyrocketed

Gritstone Oncology, Inc. (GRTS:NASDAQ) rocketted at $13.2, representing a gain of 25.7%. On Mon, Nov 29, 2021, GRTS:NASDAQ touched a New 2-Week Intraday High of $11.4. The stock got featured on our News Catalysts scanner on Mon, Nov 29, 2021 at 07:49 AM in the 'BIOTECH' category. From Mon, Nov 15, 2021, the stock recorded 55.56% Up Days and 50.00% Green Days

The stock spiked on Fri, Sep 17, 2021 at $14.36 with a volume of 5M+, and its share price has been moving sideways in recent weeks.

About Gritstone Oncology, Inc. (GRTS:NASDAQ)

Gritstone Oncology Inc is a United States based immune-oncology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors including GRANITE-001 and SLATE-001.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.